Oak Street Health, Inc. (NYSE:OSH – Get Rating) has been given an average recommendation of “Hold” by the twenty research firms that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, fourteen have issued a hold rating and two have issued a buy rating […]
Shares of Oak Street Health, Inc. (NYSE:OSH – Get Rating) have been given a consensus rating of “Hold” by the twenty brokerages that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and two have issued a buy rating on […]
Shares of Oak Street Health, Inc. (NYSE:OSH – Get Rating) have received a consensus recommendation of “Hold” from the twenty ratings firms that are presently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, fourteen have assigned a hold recommendation and two have assigned a buy recommendation […]
Oak Street Health (NYSE:OSH – Get Rating) and GeneDx (NASDAQ:WGS – Get Rating) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation. Profitability This table compares Oak Street Health and GeneDx’s net […]
Oak Street Health, Inc. (NYSE:OSH – Get Rating) insider Geoffrey M. Price sold 50,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 18th. The stock was sold at an average price of $38.88, for a total value of $1,944,000.00. Following the transaction, the insider now owns 3,879,525 shares of the […]